Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
575 studies found for:    Open Studies | "Hormones"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hormones"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
2 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
3 Unknown  Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth hormone
4 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
5 Recruiting A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Condition: Growth Hormone-Deficiency
Interventions: Drug: TV-1106;   Drug: somatropin
6 Recruiting Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Condition: Anti-Mullerian Hormone
Intervention:
7 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
8 Recruiting Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: IV administration of fluorine-18 labeled methylcholine followed by PET/CT
9 Recruiting An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
Condition: Adult Growth Hormone Deficiency
Intervention: Drug: Saizen® solution for injection (referred as Saizen®)
10 Unknown  Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: Fermented Wheat germ extract
11 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
12 Recruiting Safety, PK/PD and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Condition: Growth Hormone Deficiency (GHD)
Interventions: Drug: ACP-001;   Drug: Human Growth Hormone
13 Unknown  Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight
Conditions: Effects of Lipids on Gastric Emptying;   Effects of Lipids on Satiety Hormones;   Effects of Lipids on Appetite
Intervention:
14 Unknown  Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
Condition: Hormone Deficiency
Interventions: Drug: Growth hormone treatment;   Drug: Testosterone treatment
15 Unknown  Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Conditions: Hormone-Sensitive Breast Cancer;   Breast Cancer
Interventions: Drug: Letrozole;   Drug: Bevacizumab
16 Recruiting Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Hormone-resistant Breast Cancer;   Male Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: exemestane;   Drug: entinostat;   Drug: goserelin acetate;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
17 Unknown  Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
18 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
19 Not yet recruiting Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Exemestane;   Drug: Everolimus
20 Recruiting Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
Condition: Advanced Hormone Dependent Prostate Cancer
Intervention: Drug: Firmagon® (degarelix)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years